Federal nursing-home job aid targets a long-running staffing gap
A new federal workforce effort would use loan repayment and stipends to encourage nurses to take nursing-home jobs in underserved areas, but experts say staffing problems are broader than one program can solve.
When Cancer Drugs Run Short, Patients Feel the Gap
A Washington Post report describes how some U.S. cancer patients and clinicians are turning to overseas sources when key medicines run short. The broader pattern reflects a stubborn reality: shortages can delay treatment, force substitutions, and create new safety questions.
Trump order targets women’s health research, with menopause and aging in focus
A new White House order aims to expand federal attention to women’s health research. Here’s what it could mean, what science already shows, and what remains unclear.
Medicare open enrollment starts with bigger drug-cost changes ahead
Medicare’s open enrollment season is under way, and several policy changes scheduled for 2027 could affect drug costs, plan choices and access to widely used diabetes and weight-loss medicines.
U.S. health officials move toward wider access to controversial peptide injections
The Trump administration is advancing a policy that could make certain unapproved peptide injections easier to compound, even as FDA materials continue to flag safety and quality concerns.
U.S. and Zambia finalize a health funding deal after dropping data terms
The agreement sets a five-year health financing package while removing disputed patient-data and specimen-sharing language that had delayed the deal.
FDA maps out next wave of AI oversight for medical devices
The FDA’s new fiscal 2027 guidance list shows that artificial intelligence will remain a major focus, with planned documents on AI-enabled device software, generative AI, and related evidence standards.
Americans Worry AI Is Moving Faster Than Safeguards in Health Care
A new AP-NORC poll finds broad concern that artificial intelligence is advancing too quickly, a worry that carries special weight as AI tools expand in medicine and public health.
Canadian Mail-Order Prescriptions Face a New Hurdle
A U.S. customs change could make it harder and more expensive for some Americans to receive prescription medicines from Canada, raising fresh concerns about drug affordability and continuity of care.
When insurance delays hit COPD care, the stakes can be high
A reported death tied to delayed COPD medication highlights how coverage barriers can disrupt treatment for adults with chronic lung disease—especially after age 45.